Increase in tumor GADD153 mRNA level following treatment correlates with response to paclitaxel

Cancer Chemotherapy and Pharmacology

Volumn 45, Issue 5, 2000, Pages 381-388

  De Las Alas, Maida M ^a   Christen, Randolph D ^a,b   Gately, Dennis P ^a   Weiner, David E ^a   Benbatoul, Khalid ^a   Kirmani, Saeeda ^b   D'Agostino, Horacio R ^b   Plaxe, Steven C ^b   Darrah, Denise ^a   McClay, Edward F ^a,b   Aebi, Stefan ^a   Howell, Stephen B ^a,b   Los, Gerrit ^a,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^c UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

GADD153; MDR1; Paclitaxel

Indexed keywords

BETA ACTIN; GLYCOPROTEIN P; MESSENGER RNA; MULTIDRUG RESISTANCE PROTEIN; PACLITAXEL; PROGESTERONE;

ARTICLE; ASPIRATION BIOPSY; CANCER CHEMOTHERAPY; CELL DAMAGE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG RESPONSE; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; MULTIDRUG RESISTANCE; NORTHERN BLOTTING; OVARY ADENOCARCINOMA; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR VOLUME;

EID: 0034087587     PISSN: 03445704     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002800051006     Document Type: Article

References (33)

1. 1. Davis L, Bidner M, Battey J (1986) Basic methods in molecular biology. Elsevier, New York
2. 2. de las Alas M, Christen R, Kirmani S, d'Agostino H, Plaxe S, Darrah D, McClay E, Howell S, Los G (1996) Correlation between tumor response and change in GADD153 mRNA level in human biopsies after paclitaxel treatment. Proc Am Soc Clin Oncol 37: 571
3. 3. Delmastro D, Li J, Vaisman A, Solle M, Chaney S (1997) DNA damage-inducible gene expression following platinum treatment in human ovarian carcinoma cell lines. Cancer Chemother Pharmacol 39: 245
4. 4. DiSaia P, Sinkovics J, Rutledge F, Smith J (1972) Cell-mediated immunity to human malignant cells. A brief review and further studies with two gynecologic tumors. Am J Obstet Gynecol 114: 979
5. 5. Eymin B, Dubreaz L, Allouche M, Solary E (1997) Increased gadd153 messenger RNA level is associated with apoptosis in human leukemic cells treated with etoposide. Cancer Res 57: 686
6. 6. Fornace AJ, Nebert D, Hollander M, Luethy J, Papathanasiou M, Fargnoli J, Holbrook NJ (1989) Mammalian genes coordinately regulated by growth arrest signals and DNA-damaging agents. Mol Cell Biol 9: 4196
7. 7. Fornace Jr A, Alamo I, Hollander M (1988) DNA damage-inducible transcripts in mammalian cells. Proc Natl Acad Sci USA 85: 8800
8. 8. Gately D, Howell S (1996) Paclitaxel activation of the GADD153 promoter through a cellular injury response element containing an essential Sp1 binding site. J Biol Chem 271: 20588
9. 9. Gately D, Jones J, Christen R, Barton R, Los G, Howell S (1994) Induction of growth arrest and DNA damage-inducible gene GADD153 by cisplatin in vitro and in vivo. Br J Cancer 70: 1102
10. 10. Gately D, Sharma A, Christen R, Howell S (1996) Cisplatin and Taxol activate different signal pathways regulating cellular injury-induced expression of GADD153. Br J Cancer 73: 18
11. 11. Goldstein L, Fojo A, Ueda K, Crist W, Green A, Brodeur G, Pastan I, Gottesman M (1990) Expression of the multidrug resistance, MDR1 gene in neuroblastomas. J Natl Cancer Inst 81: 116
12. 12. Grogan T, Spier C, Salmon S, Matzner M, Rybski J, Weinstein R, Scheper R, Dalton W (1993) P-glycoprotein expression in human plasma cell myeloma: correlation with prior chemotherapy. Blood 81: 490
13. 13. Guyton K, Xu Q, Holbrook N (1996) Induction of the mammalian stress response gene GADD153 by oxidative stress: role of AP-1 element. Biochem J 314: 547
14. 14. Horikoshi T, Danenberg K, Stadlbauer T, Voleknandt M, Shea L, Aigner K, Gustavsson B, Leichman L, Frosing R, Ray M, Gibson N, Spears C, Danenberg P (1992) Quantitation of thymidylate synthase, dihydrofolate reductase, and T-diaphorase gene expression in human tumors using the polymerase chain reaction. Cancer Res 52: 108
15. 14 a. Howell SB, Gately D, Christen RD, Los G (1996) The cisplatin-induced cellular response. In: Schornagel JH, Pinedo HM (eds) Platinum and other metal coordination compounds in cancer chemotherapy. Plenum Press, New York, p 269
16. 15. Hu X, Slater A, Wall D, Kantharidis P, Parkin J, Cowman A, Zalcberg J (1995) Rapid up-regulation of MDR1 expression by anthracyclines in a classical multidrug-resistant cell line. Br J Cancer 71: 931
17. 16. Jackman J, Alamo I Jr, Fornace A Jr (1994) Genotoxic stress confers preferential and coordinate messenger RNA stability on the five gadd genes. Cancer Res 54: 5656
18. 17. Johnsson A, Strand C, Los G (1999) Expression of GADD153 in tumor cells and stromal cells from xenografted tumors in nude mice treated with cisplatin: correlations with cisplatin-DNA adducts. Cancer Chemother Pharmacol 43: 384
19. 18. Los G, Barton R, Van Veelen L, Woods A, Vicario D, Robbins K, Howell S (1994a) Association between DNA damage-inducible gene expression and tumor response. Proc Am Assoc Cancer Res 35: 550
20. 19. Los G, Barton R, Vicario D, Weisman R, Robbins KT, Howell SB (1994b) Molecular markers of tumor response in head and neck carcinoma. Head Neck 16: 509
21. 20. Los G, Weisman R, Weiner D, Benbatoul K, Van Veelen L, Barton R, de las Alas M, Christen R, Kirmani S, Orloff L, Robbins K, Howell S (1996) Identification of molecular markers reflecting the extent of injury induced in human tumors following treatment with chemotherapeutic agents. Proc Am Assoc Cancer Res 37: 135
22. 21. Los G, Benbatoul K, Gately D, Barton R, Christen R, Robbins K, Vicario D, Kirmani S, Orloff L, Weisman R, Howell S (1999) Quantitation of GADD153 mRNA levels in human malignancies: a molecular marker for the tumor injury response. Clin Cancer Res 5: 1610
23. 22. Luethy J, Holbrook N (1992) Activation of the GADD153 promoter by genotoxic agents: a rapid and specific response to DNA damage. Cancer Res 52: 5
24. 23. Luethy J, Fargnoli J, Park J, Fornace A Jr, Holbrook N (1990) Isolation and characterization of the hamster GADD153 gene. J Biol Chem 265: 16521
25. 24. Marie J, Zittoun R, Sikic B (1991) Multidrug resistance (mdr1) gene expression in adult acute leukemias: correlations with treatment outcome and in vitro drug sensitivity. Blood 78: 586
26. 25. Noonan K, Beck C, Holzmayer T, Chin J, Wunder J, Andrulis I, Gazdar A, Willman C, Griffith B, Von Hoff D, Roninson I (1990) Quantitative analysis of MDR1 (multidrug resistance) gene expression in human tumors by polymerase chain reaction. Proc Natl Acad Sci USA 87: 7160
27. 26. Ozols R (1995) Clinical reversal of drug resistance. In: Ozols R (ed) Current problems in cancer. Year Book Medical Publishers, Chicago, p 69
28. 27. Pinto A, Lippard S (1985) Binding of the antitumor drug cisdiamminedichloroplatinum(II) (cisplatin) to DNA. Biochim Biophys Acta 780: 167
29. 28. Pirker R, Goldstein L, Ludwig H, Linkesch W, Lechner C, Gottesman M, Pastan I (1989) Expression of a multidrug resistance gene in blast crisis of chronic myelogenous leukemia. Cancer Comm 1: 141
30. 29. Ron D, Habener J (1992) CHOP, a novel developmentally regulated nuclear protein that dimerizes with transcription factors C/EBP and LAP and functions as a dominant-negative inhibitor of gene transcription. Genes Dev 6: 439
31. 30. Rowinsky E, McGuire W, Donehower R (1993) The current status of Taxol. Lippincott, Philadelphia
32. 31. Sambrook J, Fritsch E, Maniatis T (1989) Molecular cloning: a laboratory manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor
33. 32. Zhan Q, Lord K, Alamo I Jr, Hollander M, Carrier F, Ron D, Kohn K, Horrman B, Liebermann D, Fornace A Jr (1994) The gadd and MyD genes define a novel set of mammalian genes encoding acidic proteins that synergistically suppress cell growth. Mol Cell Biol 14: 2361